Precision Wires India Limited moves to reshape its capital structure
TL;DR
What are the specific 'objects of the issue' for the INR 150 Cr CCDs as detailed in the board outcome—specifically, what portion is allocated to capacity expansion (capex) versus working capital, and how does this align with the company's current asset turnover and capacity utilization levels?
The Rs 150 Cr CCD issue is working-capital-heavy: Rs 90 Cr, or 60%, is earmarked for working capital, while Rs 60 Cr, or 40%, is allocated to expansion—described as capex and land acquisition. The stated deployment windows are 18 months for working capital and 24 months for expansion. [1]
† Derived as amount divided by Rs 150 Cr total issue size.
Alignment with operating metrics
- Asset turnover: The latest standalone TTM asset turnover was 3.47x in Q1 FY27 [2]. This indicates that the existing asset base is already supporting substantial sales throughput; therefore, the larger working-capital allocation is consistent with funding copper inventory and supplier liabilities behind a high-volume business rather than being purely a balance-sheet expansion exercise.
- Growth backdrop: Q1 FY27 revenue was Rs 1,770.5 Cr, up 60.4% YoY [3] [4]. In a copper-intensive business, strong revenue growth can increase funding needs even when physical volumes are unchanged because the value of inventory and procurement commitments rises.
- Capacity utilization: A current capacity-utilization percentage is not reported in the cited issue disclosure. The disclosure instead identifies a Silvassa expansion of 4,620 tonnes per annum, revised from 3,920 tonnes per annum, with net effective installed capacity expected to reach 69,200 tonnes per annum by FY28 [5]. Installed capacity should not be treated as utilization.
- Capex interpretation: The Rs 60 Cr expansion bucket is not necessarily pure plant-and-machinery capex because it includes land acquisition. The named Silvassa project itself has a stated cost of Rs 38 Cr [5], so the broader Rs 60 Cr allocation likely covers additional expansion, modernization and/or land; the exact internal split is not disclosed.
Analyst read: The funding mix suggests that near-term cash is primarily intended to support the working-capital intensity of rapid growth, while 40% provides expansion optionality. The 3.47x asset turnover supports the rationale for funding throughput, but without a disclosed utilization rate it is not possible to conclude whether the capex is needed to relieve a current capacity bottleneck or to prepare for future demand.
What are the confirmed terms of the CCDs—specifically the conversion price formula, the tenure before mandatory conversion, and the identity of the allottees—and how does the potential fully diluted equity base compare to the current outstanding share capital?
The CCD terms are a 1:1 conversion at a disclosed Rs 400 per share, with conversion after 12 months and no later than 18 months; the named allottees are Anchorage Capital Scheme III and AADI Financial Advisors. The latest exchange approval confirms the issue size and a minimum price of Rs 400, while the detailed tenure and allottee names come from the preferential-issue proposal. [6] [1] [7]
Potential dilution
The current outstanding share count is 182,807,975 shares as of 11 September 2026. Adding the potential 3,750,000 conversion shares gives a fully diluted base of:
- Current shares: 182,807,975
- Potential new shares: 3,750,000 [6]
- Potential fully diluted shares: 186,557,975
- Increase versus current base: 2.05%, derived as 3,750,000 / 182,807,975
- Existing shareholders’ pro forma ownership: approximately 97.99%, assuming no other share-capital changes
Thus, the CCD conversion would expand the equity base by roughly 2.05% relative to today’s outstanding shares. This remains a potential dilution figure: the exchange’s in-principle approval is not itself approval for final listing, and the calculation assumes full 1:1 conversion. [6]
| Term | Confirmed position |
|---|---|
| Conversion formula | Each CCD converts into one equity share of Re 1 face value at Rs 1 face value + Rs 399 premium = Rs 400 per share. The exchange approval specifies that the price cannot be below Rs 400. [6] [1] |
| Tenure / conversion timing | The CCD is compulsorily convertible. The disclosed conversion window starts after 12 months and runs up to 18 months from allotment, implying 18 months as the outer tenure. [1] |
| Allottees | Anchorage Capital Scheme III and AADI Financial Advisors. The exchange approval itself describes them only as non-promoter proposed allottees. [6] [7] |
| Issue size | 3,750,000 CCDs, converting into an equal number of equity shares. [6] |
Given Precision Wires' existing debt profile as of the latest quarterly filing, how does this INR 150 Cr infusion alter the company's debt-to-equity ratio, and does this issuance signal a shift in the company's capital allocation strategy compared to its historical reliance on internal accruals or bank debt?
The infusion does not change reported leverage immediately because the CCDs have only received in-principle approval; once allotted, leverage would rise materially if treated as debt, but fall below the current level after compulsory conversion into equity.
Debt-to-equity impact
Precision Wires’ latest reported standalone position is Q1 FY27: total debt was Rs 162.33 Cr and reported debt-to-equity was 0.21x [8] [9]. Net debt was Rs 48.01 Cr, supported by Rs 114.32 Cr of cash and equivalents [10] [11].
Using the Q1 debt and reported 0.21x ratio implies an equity base of approximately Rs 773 Cr; the estimate is subject to rounding in the reported ratio.
The proposed issue comprises 37.5 lakh CCDs of Rs 400 each, mechanically equivalent to Rs 150 Cr; the company has received in-principle approval and stated that allotment would follow, so the current reported 0.21x has not yet been reset [12]. The exchange approval also specifies conversion into 37.5 lakh equity shares at a price of at least Rs 400 per share [6].
Interpretation:
- Pre-conversion: gross D/E would temporarily increase from 0.21x to approximately 0.40x, or by about 0.19x. The CCDs are unsecured 12% instruments, implying a simple annual coupon burden of approximately Rs 18 Cr on Rs 150 Cr before conversion, based on the disclosed coupon [13].
- Post-conversion: D/E would decline to approximately 0.18x, assuming the full Rs 150 Cr is credited to equity and there are no intervening earnings, debt or cash-flow changes. The trade-off is dilution rather than permanent leverage.
- Net leverage: if the proceeds initially remain as cash, net debt would be broadly unchanged because debt and cash rise together. The economic effect will depend on how quickly the Rs 150 Cr is deployed.
Does this mark a capital-allocation shift?
Yes, but it is a broadening of the financing mix rather than a complete departure from bank debt or internal accruals. The issue introduces a sizeable equity-linked funding channel for the first time in this capital-raising plan, reducing the need to fund all working capital and expansion through retained cash or conventional borrowings.
The stated use of proceeds is also mixed: Rs 90 Cr for copper procurement and related financial liabilities, and Rs 60 Cr for expansion, including Rs 50 Cr of plant and equipment and Rs 10 Cr of land, with utilisation planned over 18-24 months [14]. Therefore, the raise is partly a balance-sheet and working-capital intervention, not solely a growth-capex raise.
It is not, however, evidence of a wholesale move away from debt. CARE Ratings said the company’s broader Rs 400-500 Cr three-year capex plan was to be funded through debt and equity/internal accruals in a 1.5:1 ratio, while the backward-integration project was also structured around a debt-equity mix [15]. The CCD issue is therefore better read as capital-source diversification and balance-sheet flexibility, with equity-linked funding supplementing—not replacing—bank debt and internal accruals.
Main caveat: the 0.40x and 0.18x figures are pro forma analytical scenarios. The actual reported ratio will depend on the accounting classification of the CCDs, allotment timing, interim profits, cash deployment and the eventual conversion terms.
| Scenario | Gross debt | Equity base | Implied gross D/E |
|---|---|---|---|
| Latest Q1 FY27 position | Rs 162.33 Cr [8] | Approx. Rs 773 Cr, implied from reported D/E [9] | 0.21x [9] |
| After CCD allotment, before conversion | Rs 312.33 Cr, derived by adding Rs 150 Cr | Approx. Rs 773 Cr | Approx. 0.40x |
| After compulsory conversion | Rs 162.33 Cr | Approx. Rs 923 Cr, derived by adding Rs 150 Cr | Approx. 0.18x |
Sources
- [1]Precision Wires India CCD issue: ₹150 crore plan 2026 — Multibagg, 2026-08-21T00:00:00
- [2]TTM Asset Turnover
- [3]Revenue INR
- [4]Revenue INR YoY
- [5]Precision Wires Q1 profit zooms 72% on 60% revenue growth; plans ₹150 crore CCD issue - CNBC TV18 — CNBC TV18, 2026-08-10T00:00:00
- [6]Precision Wires India receives in-principle approval for INR 150 Cr preferential issue of Compulsorily Convertible Debentures. — 2026-09-12T12:30:35, p.4
- [7]Precision Wires India To Host Analyst and Investor Meeting On August 22 — Sahi, 2026-08-19T00:00:00
- [8]Total Debt
- [9]Debt Equity Ratio
- [10]Net Debt
- [11]Latest Cash and Equivalents
- [12]Precision Wires India receives in-principle approval for INR 150 Cr preferential issue of Compulsorily Convertible Debentures. — 2026-09-12T12:30:35, p.1
- [13]Precision Wires India shareholders approve ₹150 crore CCD issue — Scanx, 2026-09-05T00:00:00
- [14][PDF] PRECISION WIRES INDIA LIMITED - NSE — Nsearchives, 2026-08-21T00:00:00
- [15]Precision Wires India Limited — Careratings, 2026-07-09T00:00:00
Keep digging